T2 Biosystems Inc reports results for the quarter ended in March - Earnings Summary

T2 Biosystems

07/05/2024 24:19

* T2 Biosystems Inc  TTOO.OQ  reported a quarterly adjusted
loss
of $2.66​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of
$-132.00.  The lone analyst forecast for the quarter was for a
loss of $1.86 per share. 
    * Revenue fell 0.8% to $2.06 million from a year ago;
analysts
expected $1.60 million. 
    * T2 Biosystems Inc's reported EPS for the quarter was a
loss of
$2.66​.
    * The company reported a quarterly loss of $13.53 million.
    * T2 Biosystems Inc shares had risen by 24.0% this
quarter and
lost 40.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 18.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"

Wall Street's median 12-month price target for T2 Biosystems Inc
is $3.00 
This summary was machine generated from LSEG data May 6 at 11:19
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.86          -2.66          Missed
                                  -3.96          
 Sep. 30 2023      -3.85          -3.45          Beat
 Jun. 30 2023      -26.67         -8.00          Beat